Home  >  Products  >  CCDC50 (coiled-coil domain containing 50) Blocking Peptide (the middle region of CCDC50)(100ug)
CCDC50 (coiled-coil domain containing 50) Blocking Peptide (the middle region of CCDC50)(100ug)

CCDC50 (coiled-coil domain containing 50) Blocking Peptide (the middle region of CCDC50)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CCDC50 Antibody(ARP53356_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP53356
Size: 100ug
Weight: 56kDa
Gene: 152137
Format: Lyophilized powder
Target: CCDC50 is a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling.
Alternative names: C3orf6; DFNA44; YMER
See Full Product Listings >